Literature DB >> 11164510

Nucleus accumbens, entorhinal cortex and latent inhibition: a neural network model.

N A Schmajuk1, L Cox, J A Gray.   

Abstract

A neural network model of classical conditioning (Schmajuk, Lam, and Gray, J. Exp. Psychol.: Anim. Behav. Process, 22, 1996, 321-349) is applied to the description of the neural substrates of latent inhibition. Experimental data suggest that latent inhibition might be controlled by a circuit that involves the hippocampus, the entorhinal cortex, the nucleus accumbens, and the mesolimbic dopaminergic projection from the ventral tegmental area to the accumbens. By mapping different nodes and connections in the model onto this brain circuit, computer simulations demonstrate that, in most cases, the model provides a good quantitative description of: (1) the impairment of latent inhibition by lesions of the shell of the nucleus accumbens; (2) the restoration of latent inhibition by haloperidol following lesions of the shell; (3) the preservation of latent inhibition by lesions of the core of the nucleus accumbens; (4) the facilitation of latent inhibition by combined shell core lesions and by core lesions with extended conditioning; (5) the impairment of latent inhibition following lesions of the entorhinal cortex or the hippocampus; and (6) the restoration of latent inhibition by haloperidol following lesions of the entorhinal cortex and ventral subiculum. In addition, the model is able to describe neural activity in the nucleus accumbens.

Mesh:

Substances:

Year:  2001        PMID: 11164510     DOI: 10.1016/s0166-4328(00)00319-3

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  15 in total

1.  Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia.

Authors:  R Andrew Chambers; David W Self
Journal:  Neuropsychopharmacology       Date:  2002-12       Impact factor: 7.853

2.  Reinstatement of conditioned fear and the hippocampus: an attentional-associative model.

Authors:  Nestor A Schmajuk; José A Larrauri; Kevin S Labar
Journal:  Behav Brain Res       Date:  2006-12-18       Impact factor: 3.332

3.  Disruption of the US pre-exposure effect and latent inhibition in two-way active avoidance by systemic amphetamine in C57BL/6 mice.

Authors:  Tilly Chang; Urs Meyer; Joram Feldon; Benjamin K Yee
Journal:  Psychopharmacology (Berl)       Date:  2006-12-19       Impact factor: 4.530

4.  Examining associations between psychosis risk, social anhedonia, and performance of striatum-related behavioral tasks.

Authors:  Nicole R Karcher; Elizabeth A Martin; John G Kerns
Journal:  J Abnorm Psychol       Date:  2015-08

Review 5.  The debate over dopamine's role in reward: the case for incentive salience.

Authors:  Kent C Berridge
Journal:  Psychopharmacology (Berl)       Date:  2006-10-27       Impact factor: 4.530

6.  A pre-clinical study showing how dopaminergic drugs administered during pre-exposure can impair or facilitate latent inhibition.

Authors:  N A Schmajuk; J A Gray; J A Larrauri
Journal:  Psychopharmacology (Berl)       Date:  2004-08-13       Impact factor: 4.530

7.  Reelin haploinsufficiency reduces the density of PV+ neurons in circumscribed regions of the striatum and selectively alters striatal-based behaviors.

Authors:  Martine Ammassari-Teule; Carmelo Sgobio; Filippo Biamonte; Cristina Marrone; Nicola B Mercuri; Flavio Keller
Journal:  Psychopharmacology (Berl)       Date:  2009-03-10       Impact factor: 4.530

8.  Functional networks underlying latent inhibition learning in the mouse brain.

Authors:  Frank Puga; Douglas W Barrett; Christel C Bastida; F Gonzalez-Lima
Journal:  Neuroimage       Date:  2007-07-18       Impact factor: 6.556

9.  Prenatal and postnatal maternal contributions in the infection model of schizophrenia.

Authors:  Urs Meyer; Severin Schwendener; Joram Feldon; Benjamin K Yee
Journal:  Exp Brain Res       Date:  2006-03-22       Impact factor: 1.972

10.  Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia.

Authors:  L Zuckerman; N Rimmerman; I Weiner
Journal:  Psychopharmacology (Berl)       Date:  2003-06-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.